Note: Ingredients listed on restricted chemical lists
EC/CAS
200-338-0/57-55-6
Name of the chemical
1,2-propanediol
Concentration
≤60
General Information
Revision date
2016-12-13
Product name
PolyDetector HRP Blue Substrate Chromogen Kit
1.2.1 Relevant identified uses
Immunohistochemistry (IHC) reagent for detection/ancillary reagent Not intended for use in humans or animals
Manufacturer Name
Bio SB, Inc
Emergency telephone
+1-805-692 2768
Icons in SDS
Company Information
company name
Bio SB, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
info@biosb.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H319, H341, H350
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
(EC) No. 1272/2008 Classification of the mixture
Contains
BIPHENYL-3,3',4,4'-TETRAYL-TETRAAMONIUM TERACHLORIDE
Hazard pictograms
GHS08
Signal word
Danger
Hazard statements
H302 Acute toxicity, Oral (Category 4) H319 Eye Irritation (Category 2A) H341 Suspected of causing genetic defects. H350 May cause cancer.
Prevention
P201 Obtain special instructions before use P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective clothing, gloves, wear eye and face protection.
Response
P308+313 IF exposed or concerned: Get medical advice/attention.
Storage
P405 Store locked up P501 Dispose of contents and container in accordance with all local, regional, national and international regulations
2.3 Other hazards
None known
2.1 Classification of the substance or mixture
Classification OSHA/HCS Status (29 CFR 1920.1200) According to OSHA Hazard Communication Standard this mixture is classified as hazardous Classification (EC 1272/2008) According to Regulation (EC) No. 1271/2008 this mixture is classified as hazardous Human health H302 Acute Toxicity (Category 4) H319 Eye Irritation (Category 2A) H341 Germ Cell Mutagenicity Category 2 H350 Carcinogenicity Category 1B For the full Text for all Hazard Statements mentioned in this Section, see Section 16.
